Meningioma: Review of the literature with emphasis on the approach to radiotherapy

Expert Review of Anticancer Therapy

Volumn 11, Issue 11, 2011, Pages 1749-1758

  Marta, Gustavo Nader ^a   Correa, Sebastião Francisco Miranda ^a,b   Teixeira, Manoel Jacobsen ^c  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

^b Unit of Cardiac Surgery   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Epidemiology; Meningioma; Radiotherapy; Surgery

Indexed keywords

ADJUVANT RADIOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAROTID ARTERY OBSTRUCTION; CAUSE SPECIFIC SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL RADIOTHERAPY; CRANIAL NEUROPATHY; CYST; DIFFERENTIAL DIAGNOSIS; EYE MOVEMENT DISORDER; FOLLOW UP; FRACTIONATED STEREOTACTIC RADIOSURGERY; HEMANGIOPERICYTOMA; HISTOPATHOLOGY; IMAGING; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LYMPHOMA; MENINGIOMA; METASTASIS; MORBIDITY; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; OPTIC NERVE INJURY; OPTIC TRACT INJURY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PROGRESSION FREE SURVIVAL; REVIEW; SARCOIDOSIS; STEREOTACTIC RADIOSURGERY; SURVIVAL RATE; TRIGEMINAL NERVE DISEASE; TUBERCULOSIS; WEGENER GRANULOMATOSIS; DURA MATER; HUMAN; PATHOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); RADIATION EXPOSURE;

CLINICAL TRIALS, PHASE II AS TOPIC; DURA MATER; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA;

EID: 84858727893     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.11.162     Document Type: Review

References (79)

1. Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet 363(9420), 1535-1543 (2004).
2. Bauman G, Fisher B, Schild S, Shaw EG. Meningioma, ependymoma, and other adult brain tumors. In: Clinical Radiation Oncology. Gunderson LL, Tepper JE (Eds). Elsevier Churchill Livingstone, Philadelphia, PA, USA, 539-566 (2007).
3. Blitshteyn S, Crook JE, Jaeckle KA. Is there an association between meningioma and hormone replacement therapy? J. Clin. Oncol. 26(2), 279-282 (2008).
4. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma. Neurosurgery 57(6), 1088-1095 (2005).
5. Umansky F, Shoshan Y, Rosenthal G, Fraifeld S, Spektor S. Radiation-induced meningioma. Neurosurg. Focus 24(5), E7 (2008).
6. Maxwell M, Shih SD, Galanopoulos T, Hedley-Whyte ET, Cosgrove GR. Familial meningioma: analysis of expression of neurofibromatosis 2 protein merlin. Report of two cases. J. Neurosurg. 88(3), 562-569 (1998).
7. Liu Y, Li F, Zhu S, Liu M, Wu C. Clinical features and treatment of meningiomas in children: report of 12 cases and literature review. Pediatr. Neurosurg. 44(2), 112-117 (2008).
8. Marosi C, Hassler M, Roessler K et al. Meningioma. Crit. Rev. Oncol. Hematol. 67(2), 153-171 (2008).
9. Banerjee J, Paakko E, Harila M et al. Radiation-induced meningiomas: a shadow in the success story of childhood leukemia. Neuro Oncol. 11(5), 543-549 (2009).
10. Bosnjak R, Derham C, Popovic M, Ravnik J. Spontaneous intracranial meningioma bleeding: clinicopathological features and outcome. J. Neurosurg. 103(3), 473-484 (2005).
11. Anderson D, Khalil M. Meningioma and the ophthalmologist. A review of 80 cases. Ophthalmology 88(10), 1004-1009 (1981).
12. Vernooij MW, Ikram MA, Tanghe HL et al. Incidental findings on brain MRI in the general population. N. Engl. J. Med. 357(18), 1821-1828 (2007).
13. Elster AD, Challa VR, Gilbert TH, Richardson DN, Contento JC. Meningiomas: MR and histopathologic features. Radiology 170(3 Pt 1), 857-862 (1989).
14. Cha S. Neuroimaging in neuro-oncology. Neurotherapeutics 6(3), 465-477 (2009).
15. Giannini, C, Rushing, EJ, Hainfellner, JA. Haemangiopericytoma. In: WHO Classification of Tumours of the Central Nervous System. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Eds). IARC Press, Lyon, France, 178 (2007).
16. Hsu CC, Pai CY, Kao HW et al. Do aggressive imaging features correlate with advanced histopathological grade in meningiomas? J. Clin. Neurosci. 17, 584 (2010).
17. Hanft S, Canoll P, Bruce JN. A review of malignant meningiomas: diagnosis, characteristics, and treatment. J. Neurooncol. 99, 433 (2010).
18. Yang SY, Park CK, Park SH et al. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J. Neurol. Neurosurg. Psychiatry 79(5), 574-580 (2008).
19. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. ‘Malignancy’ in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85(9), 2046-2056 (1999).
20. Taieb G, Campello C, Renard D et al. Multifocal extracranial meningioma metastases. Arch. Neurol. 68(3), 388-389 (2011).
21. Teague SD, Conces DJ Jr. Metastatic meningioma to the lungs. J. Thorac. Imaging 20, 58-60 (2005).
22. Erman T, Hanta I, Haciyakupoglu S, Zorludemir S, Zeren H, Göçer A. Huge bilateral pulmonary and pleural metastasis from intracranial meningioma: a case report and review of the literature. J. Neurooncol. 74, 179-1814 (2005).
23. Drummond KJ, Zhu J-J, Black PM. Meningiomas. updating, basic science, management, and outcome. Neurologist 10, 113-130 (2004).
24. Johnson MD, Sade B, Milano MT, Lee JH, Toms SA. New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J. Neurooncol. 86, 109-122 (2008).
25. Johnson MD, Powell SZ, Boyer PJ, Weil RJ, Moots PL. Dural lesions mimicking meningiomas. Hum. Pathol. 33(12), 1211-1226 (2002).
26. Yano S, Kuratsu J. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J. Neurosurg. 105(4), 538-543 (2006).
27. Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery 53(1), 62-70; discussion 70-71 (2003).
28. Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G. Natural history of conservatively treated meningiomas. Neurology 63, 1133 (2004).
29. Bendszus M, Monoranu CM, Schütz A, Nölte I, Vince GH, Solymosi L. Neurologic complications after particle embolization of intracranial meningiomas. AJNR Am. J. Neuroradiol. 26(6), 1413-1419 (2005).
30. Carli DF, Sluzewski M, Beute GN, van Rooij WJ. Complications of particle embolization of meningiomas: frequency, risk factors, and outcome. AJNR Am. J. Neuroradiol. 31(1), 152-154 (2010).
31. Black P, Kathiresan S, Chung W. Meningioma surgery in the elderly: a case-control study assessing morbidity and mortality. Acta Neurochir. (Wien.) 140, 1013 (1998).
32. Sacko O, Sesay M, Roux FE et al. Intracranial meningioma surgery in the ninth decade of life. Neurosurgery 61(5), 950-954; discussion 955 (2007).
33. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31(1), 2-12 (1992).
34. Simpson DO. The recurrence of intracranial meningiomas after surgical treatment. J. Neurol. Neurosurg. Psychiatry 20, 22-39 (1957).
35. Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. J. Neurosurg. 80, 195-201 (1994).
36. Nutting C, Brada M, Brazil L et al. Radiotherapy in the treatment of benign meningioma of the skull base. J. Neurosurg. 90, 823-827 (1999).
37. Mendenhall WM, Morris CG, Amdur RJ, Foote KD, Friedman WA. Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer 98, 1473-1482 (2003).
38. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int. J. Radiat. Oncol. Biol. Phys. 30, 755-763 (1994).
39. Aghi MK, Carter BS, Cosgrove GR et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64, 56-60 (2009).
40. Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM. RT in the treatment of partially resected meningiomas. Neurosurgery 20, 525-528 (1987).
41. Peele KA, Kennerdell JS, Maroon JC et al. The role of postoperative irradiation in the management of sphenoid wing meningiomas. Ophthalmology 103, 1761-1766 (1996).
42. Vendrely V, Maire JP, Darrouzet V et al. Fractionated radiotherapy of intracranial meningiomas: 15 years’ experience at the Bordeaux University Hospital Center. Cancer Radiother. 3, 311-317 (1999).
43. Dufour H, Muracciole X, Métellus P, Régis J, Chinot O, Grisoli F. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is here an alternative to aggressive tumor removal? Neurosurgery 48, 285-294 (2001).
44. Pirzkall A, Carol M, Lohr F, Höss A, Wannenmacher M, Debus J. Comparison of intensity-modulated radiotherapy with conventional conformal radiotherapy for complex-shaped tumors. Int. J. Radiat. Oncol. Biol. Phys. 48(5), 1371-1380 (2000).
45. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensitymodulated radiotherapy current status and issues of interest. Int. J. Radiat. Oncol. Biol. Phys. 51, 880-914 (2001).
46. Uy NW, Woo SY, Teh BS et al. Intensitymodulated radiation therapy (IMRT) for meningioma. Int. J. Radiat. Oncol. Biol. Phys. 53, 1265-1270 (2002).
47. Pirzkall A, Debus J, Haering P et al. Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. Int. J. Radiat. Oncol. Biol. Phys. 55, 362-372 (2003).
48. Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base, long-term experience of a single institution. Int. J. Radiat. Oncol. Biol. Phys. 68, 858-863 (2007).
49. Sajja R, Barnett GH, Lee SY et al. Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results. Technol. Cancer Res. Treat. 4, 675-682 (2005).
50. Kondziolka D, Mathieu D, Lunsford LD et al. Radiosurgery as definitive management of intracranial meningiomas. Neurosurgery 62, 53-60 (2008).
51. Chang SD, Adler JR Jr, Martin DP. LINAC radiosurgery for cavernous sinus meningiomas. Stereotact. Funct. Neurosurg. 71, 43-50 (1998).
52. Hudgins WR, Barker JL, Schwartz DE, Nichols TD. Gamma Knife treatment of 100 consecutive meningiomas. Stereotact. Funct. Neurosurg. 1, 121-128 (1996).
53. Morita A, Coffey RJ, Foote RL, Schiff D, Gorman D. Risk of injury to cranial nerves after Gamma Knife radiosurgery for skull base meningiomas: experience in 88 patients. J. Neurosurg. 90, 42-49 (1999).
54. Roche PH, Régis J, Dufour H et al. Gamma Knife radiosurgery in the management of cavernous sinus meningiomas. J. Neurosurg. 3, 68-73 (2000).
55. Stafford SL, Pollock BE, Foote RL et al. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 49, 1029-1037 (2001).
56. Kollová A, Liscák R, Novotný J, Vladyka V, Simonová G, Janousková L. Gamma Knife surgery for benign eningioma. J. Neurosurg. 107, 325-336 (2007).
57. Feigl GC, Samii M, Horstmann GA. Volumetric follow-up of meningiomas:a quantitative method to evaluate treatment outcome of Gamma Knife radiosurgery. Neurosurgery 61, 281-286 (2007).
58. Minniti G, Clarke E, Cavallo L et al. Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas. Radiat. Oncol. 6, 36 (2011).
59. Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA. Stereotactic radiosurgery provides equivalent tumor control to Simpson grade 1 resection for patients with small- to-medium-size meningiomas. Int. J. Radiat. Oncol. Biol. Phys. 55(4), 1000-1005 (2003).
60. Maruyama K, Shin M, Kurita H, Kawahara N, Morita A, Kirino T. Proposed treatment strategy for cavernous sinus meningioma: a prospective study. Neurosurgery 55(5), 1068-1075 (2004).
61. Nicolato A, Foroni R, Alessandrini F, Bricolo A, Gerosa M. Radiosurgical treatment of cavernous sinus meningiomas: experience with 122 treated patients. Neurosurgery 51(5), 1153-1159; discussion 1159-1161 (2002).
62. Lee JY, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J. Neurosurg. 97(1), 65-72 (2002).
63. Liscák R, Simonová G, Vymazal J, Janousková L, Vladyka V. Gamma Knife radiosurgery of meningiomas in the cavernous sinus region. Acta Neurochir. (Wien.) 141(5), 473-480 (1999).
64. Kimball MM, Friedman WA, Foote KD, Bova FJ, Chi YY. Linear accelerator radiosurgery for cavernous sinus meningiomas. Stereotact. Funct. Neurosurg. 87(2), 120-127 (2009).
65. Stafford SL, Pollock BE, Leavitt JA et al. A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 55(5), 1177-1181 (2003).
66. Steinvorth S, Welzel G, Fuss M et al. Neuropsychological outcome after fractionated stereotactic radiotherapy (FSRT) for base of skull meningiomas: a prospective 1-year follow-up. Radiother. Oncol. 69, 177-182 (2003).
67. Debus J, Wuendrich M, Pirzkall A et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J. Clin. Oncol. 19, 3547-3553 (2001).
68. Torres RC, Frighetto L, De Salles AA et al. Radiosurgery and stereotactic radiotherapy for intracranial meningiomas. Neurosurg. Focus 14, e5 (2003).
69. Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 61, 809-816 (2005).
70. Hamm K, Henzel M, Gross MW, Surber G, Kleinert G, Engenhart-Cabillic R. Radiosurgery/stereotactic radiotherapy in the therapeutical therapeutical concept for skull base meningiomas. Zentralbl. Neurochir. 69, 14-21 (2008).
71. Litré CF, Colin P, Noudel R et al. Fractionated stereotactic radiotherapy treatment of cavernous sinus meningiomas: a study of 100 cases. Int. J. Radiat. Oncol. Biol. Phys. 4, 1012-1017 (2009).
72. Milker-Zabel S, Zabel-du Bois A, Huber P et al. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas. Strahlentherapie und Onkologie 182(11), 635-640 (2006).
73. Brell M, Villà S, Teixidor P, Lucas A, Ferrán E, Marín S, Acebes JJ. Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and tolerance. Surg. Neurol. 65(1), 28-33 (2006).
74. Khoo VS, Adams EJ, Saran F et al. A Comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas. Int. J. Radiat. Oncol. Biol. Phys. 46(5), 1309-1317 (2000).
75. Goldsmith B, McDermott MW. Meningioma. Neurosurg. Clin. N. Am. 17(2), 111-120 (2006).
76. Wenkel E, Thornton AF, Finkelstein D et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 48, 1363-1370 (2000).
77. Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP. Stereotactic proton beam therapy of skull base meningiomas. Int. J. Radiat. Oncol. Biol. Phys. 49, 99-105 (2001).
78. Weber DC, Lomax AJ, Rutz HP et al.; Swiss Proton Users Group. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother. Oncol. 71, 251-258 (2004). 101 ClinicalTrials.gov http://clinicaltrials.gov (Accessed 21 June 2011)
79. Clinical practice guidelines in oncology. Central nervous system cancer 2011 www.nccn.org/professionals/physician_gls/pdf/cns.pdf (Accessed 21 June 2011)